Naturhouse Health, S.A. (NTH.MC)
- Previous Close
1.7850 - Open
1.7500 - Bid 1.7550 x --
- Ask 1.7850 x --
- Day's Range
1.7350 - 1.8150 - 52 Week Range
1.6000 - 2.4000 - Volume
27,972 - Avg. Volume
22,269 - Market Cap (intraday)
107.01M - Beta (5Y Monthly) 0.57
- PE Ratio (TTM)
11.16 - EPS (TTM)
0.1600 - Earnings Date --
- Forward Dividend & Yield 0.25 (14.01%)
- Ex-Dividend Date Apr 3, 2025
- 1y Target Est
--
Naturhouse Health, S.A. operates in the nutrition and dietetics industry in Spain, Italy, France, Poland, and internationally. The company sells food supplements that are made from natural extracts to facilitate the consumption of various nutrients; and foods and drinks, such as diet products for breakfast, snacks, and meal substitutes. It offers cosmetics and body care products, including beauty products related to skincare during the slimming process comprising cellulite, firming products, etc.; and anti-ageing products. In addition, the company engages in marketing, production, and preparation of dietary products; and marketing of herbal remedies, and natural cosmetics. It sells its products through directly operated stores and franchised Naturhouse centers. The company was formerly known as Housediet, S.L.U. and changed its name to Naturhouse Health, S.A. Naturhouse Health, S.A. was incorporated in 1991 and is based in Madrid, Spain. Naturhouse Health, S.A. operates as a subsidiary of Kiluva S.A.
www.naturhouse.com191
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: NTH.MC
View MorePerformance Overview: NTH.MC
Trailing total returns as of 5/19/2025, which may include dividends or other distributions. Benchmark is IBEX 35... (^IBEX) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: NTH.MC
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: NTH.MC
View MoreValuation Measures
Market Cap
107.01M
Enterprise Value
88.38M
Trailing P/E
11.16
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.17
Price/Book (mrq)
3.38
Enterprise Value/Revenue
1.79
Enterprise Value/EBITDA
5.65
Financial Highlights
Profitability and Income Statement
Profit Margin
19.96%
Return on Assets (ttm)
17.96%
Return on Equity (ttm)
31.65%
Revenue (ttm)
49.42M
Net Income Avi to Common (ttm)
9.86M
Diluted EPS (ttm)
0.1600
Balance Sheet and Cash Flow
Total Cash (mrq)
20.68M
Total Debt/Equity (mrq)
13.48%
Levered Free Cash Flow (ttm)
6.15M